{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:42:03Z","timestamp":1780742523901,"version":"3.54.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Pancreatic metastases from other malignant tumors are an uncommon clinical condition and account for approximately 2% of all pancreatic malignancies. The most common primary malignancy that metastasizes to pancreas is renal cell cancer. We reported a rare clinical case of metastatic melanoma to pancreas who underwent a successful laparoscopic pancreaticoduodenectomy (LPD) at our department.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 54-year-old Chinese man complaining an unexplained jaundice was found to have a pancreatic mass and he was diagnosed with cutaneous melanoma (CM) 6 years ago.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Contrast-enhanced computed tomography (CECT) revealed a solid hypovascular mass measuring about 3.1\u200a\u00d7\u200a2.4\u200acm localized at the junction of pancreatic head and uncinate process, which compressed the lower common bile duct resulting in expansion of the upstream bile ducts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>We performed an LPD and regional lymphadenectomy on this patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>This patient was discharged home on postoperative day 19. Postoperative pathological results revealed a malignant melanoma with negative margins. Immunohistochemical (IHC) findings also suggested a malignant pancreatic tumor accompanied by necrosis and pigmentation, which confirmed the pathological diagnosis. Immunoreactivity was strongly positive for anti-S-100 protein (+++) and positive for anti-Vimentin (+). The cancer cells were negative for CEA, CK8\/18, P53, Violin, CK19, SMA with Ki-67 over 40%. So this pancreatic mass was proved to be a metastatic pancreatic melanoma from the primary cutaneous lesion. After LPD, this patient was followed up by readmission to hospital every 2 month in the first half year. The serum bilirubin and tumor markers such as CA199 were normal. CECT and did not find any newly developed neoplasm at the pancreas or metastasis at other organs. At the last follow-up at 6 months after LPD, the patient's general condition was acceptable and the physical examination and imaging studies revealed no significant findings of melanoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Metastatic pancreatic tumors are often associated with well-defined margins, tumor necrosis, enhancement, and distant metastases without pancreatic duct dilatation and parenchymal atrophy. As the most common type of metastatic pancreatic tumor, renal cell cancers tend to have higher attenuation values than that of primary pancreatic cancer, while they had similar attenuation values on the portal phase. Primary pancreatic cancer was always associated with an elevated CA199, total bilirubin, and fasting plasma glucose levels. Surgical resection for metastases to pancreas should be aggressively considered in selected patients due to its unique value of providing palliation and a chance to cure. For patients with unresectable lesions, new therapeutic protocols should be recommended such as the combination of BRAF with MEK inhibitor and PD-1 blocker with or without ipilimumab.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000012940","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T23:41:29Z","timestamp":1541029289000},"page":"e12940","source":"Crossref","is-referenced-by-count":8,"title":["Laparoscopic pancreaticoduodenectomy for metastatic pancreatic melanoma"],"prefix":"10.1097","volume":"97","author":[{"given":"Xueqing","family":"Liu","sequence":"first","affiliation":[{"name":"Second Hospital of Hebei Medical University, Shijiazhuang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[{"name":"Second Hospital of Hebei Medical University, Shijiazhuang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Second Hospital of Hebei Medical University, Shijiazhuang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhang","family":"Qin","sequence":"additional","affiliation":[{"name":"Second Hospital of Hebei Medical University, Shijiazhuang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Yin","sequence":"additional","affiliation":[{"name":"People's Hospital of Pingxiang, Xingtai, Hebei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqing","family":"Meng","sequence":"additional","affiliation":[{"name":"People's Hospital of Pingxiang, Xingtai, Hebei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Yan","sequence":"additional","affiliation":[{"name":"Second Hospital of Hebei Medical University, Shijiazhuang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiang","family":"Xing","sequence":"additional","affiliation":[{"name":"Second Hospital of Hebei Medical University, Shijiazhuang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Duan","sequence":"additional","affiliation":[{"name":"Second Hospital of Hebei Medical University, Shijiazhuang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[{"name":"Fudan University Shanghai Cancer Center, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[{"name":"Second Hospital of Hebei Medical University, Shijiazhuang"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4251\/wjgo.v6.i10.381","article-title":"Metastatic tumors to the pancreas: the role of surgery","volume":"6","author":"Sperti","year":"2014","journal-title":"World J Gastrointest Oncol"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamasurg.2017.0459","article-title":"Association of surgical treatment, systemic therapy, and survival in patients with abdominal visceral melanoma metastases, 1965\u20132014","volume":"152","author":"Deutsch","year":"2017","journal-title":"JAMA Surg"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MPA.0b013e3181bae9b3","article-title":"Analysis of prognostic factors in metastatic tumors of the pancreas: a single-center experience and review of the literature","volume":"39","author":"Masetti","year":"2010","journal-title":"Pancreas"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1245\/s10434-014-3821-4","article-title":"Long-term survival after pancreatic resection for renal cell carcinoma metastasis","volume":"21","author":"Schwarz","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R5-20230914","first-page":"567","article-title":"Pancreatic resection for metastatic melanoma originating from the nasal cavity: a case report and literature review","volume":"33","author":"Sugimoto","year":"2013","journal-title":"Anticancer Res"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jamcollsurg.2010.08.017","article-title":"Metastatic tumors in the pancreas in the modern era","volume":"211","author":"Konstantinidis","year":"2010","journal-title":"J Am Coll Surg"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clinre.2012.05.013","article-title":"Clinicoradiologic characteristics and outcomes of metastatic cancer to the pancreas and double primary pancreatic cancer","volume":"37","author":"Yun","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.ejrad.2015.08.007","article-title":"Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: use of relative percentage washout value and its clinical implication","volume":"84","author":"Kang","year":"2015","journal-title":"Eur J Radiol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11547-014-0473-1","article-title":"(18)F-FDG-PET\/CT findings in pancreatic metastasis","volume":"120","author":"Hu","year":"2015","journal-title":"Radiol Med"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.5858\/arpa.2015-0200-RA","article-title":"Metastases to the pancreas encountered on endoscopic ultrasound-guided, fine-needle aspiration","volume":"139","author":"Pang","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/2303-9027.156746","article-title":"Multiple pancreatic metastases from malignant melanoma: conclusive diagnosis with endoscopic ultrasound-guided fine needle aspiration","volume":"4","author":"Jana","year":"2015","journal-title":"Endosc Ultrasound"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/ijc.28625","article-title":"Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis","volume":"134","author":"Bishop","year":"2014","journal-title":"Int J Cancer"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/0284186X.2016.1143117","article-title":"Primary mucosal melanoma of the head and neck in Denmark, 1982\u20132012: demographic and clinical aspects. A retrospective DAHANCA study","volume":"55","author":"Lawaetz","year":"2016","journal-title":"Acta Oncol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(09)70065-8","article-title":"The role of surgery in the management of isolated metastases to the pancreas","volume":"10","author":"Reddy","year":"2009","journal-title":"Lancet Oncol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00268-001-0027-2","article-title":"Surgery for abdominal metastases of cutaneous melanoma","volume":"25","author":"Gutman","year":"2001","journal-title":"World J Surg"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2015.09.013","article-title":"Survival of patients with advanced metastatic melanoma: the impact of novel therapies","volume":"53","author":"Ugurel","year":"2016","journal-title":"Eur J Cancer"},{"key":"R17-20230914","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-017-0179-6","article-title":"Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review","volume":"36","author":"Simon","year":"2017","journal-title":"Chin J Cancer"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"Schadendorf","year":"2015","journal-title":"J Clin Oncol"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.humpath.2013.02.007","article-title":"Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update","volume":"45","author":"Ord\u00e3 \u00c3 Ez","year":"2014","journal-title":"Hum Pathol"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/PAI.0b013e318279bc0a","article-title":"SOX10 expression in malignant melanoma, carcinoma, and normal tissues","volume":"21","author":"Mohamed","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R21-20230914","first-page":"1393","article-title":"High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi","volume":"8","author":"Chin","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5021\/ad.2016.28.5.548","article-title":"Expression of phosphatase and tensin homologue, phospho-Akt, and p53 in acral benign and malignant melanocytic neoplasms (benign nevi, dysplastic nevi, and acral melanomas)","volume":"28","author":"Lyu","year":"2016","journal-title":"Ann Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811020-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:14:25Z","timestamp":1694715265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811020-00020"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":22,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012940","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}